ViaNautis Bio welcomed SCI Ventures as new investor, expanding CNS portfolio into spinal cord injury ViaNautis Bio, the biotech developing polyNaut® for precise, non‑viral delivery of genetic medicines, announced that SCI Ventures, a specialist venture fund backed by leading clinical centres and research foundations worldwide focused on advancing treatments and cures for paralysis, has joined the […]
Industry symposium to explore local delivery of combination antibiotics across spine and arthroplasty Poster showcases the efficacy of STIMULAN® calcium sulfate beads, loaded with a combination of Gram-positive and Gram-negative antibiotics, against S. aureus biofilms Keele, UK, 9 September 2026 – Biocomposites, an international medical devices company that engineers, manufactures and markets world-leading products for […]
STIMULAN® certified to be mixed with a combination of Gram-positive and Gram-negative antibiotics STIMULAN® certified to resolve infection and reduce the need for secondary surgery STIMULAN® is the only calcium matrix antibiotic carrier certified for use in bone and surrounding soft tissue Keele, UK, 5 February 2026 – Biocomposites, an international medical devices company that […]
Biocomposites launches SYNICEM™ spacers in Canada Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, has launched its SYNICEM™ hip, knee and shoulder preformed spacers in Canada. It follows the launch of the same products in the US last October. Biocomposites, […]
Novo Nordisk Foundation grants DKK 5.5 billion to elevate innovation in Denmark and Europe The Novo Nordisk Foundation has allocated up to DKK 5.5 billion (EUR 736 million) to the BioInnovation Institute (BII), a leading institute for life science and deep tech innovation in Copenhagen. The funding will enable BII to expand its activities into […]
